Novo Holdings A/S - 23 Feb 2022 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc.

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel, Novo Holdings A/S
Issuer symbol
N/A
Transactions as of
23 Feb 2022
Net transactions value
-$23,067
Form type
4
Filing time
25 Feb 2022, 17:21:41 UTC
Previous filing
09 Feb 2022
Next filing
15 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPI Common Stock Sale $5,277 -1,820 -0.08% $2.90 2,168,280 23 Feb 2022 Direct
transaction CMPI Common Stock Sale $16,979 -5,990 -0.28% $2.83 2,162,290 24 Feb 2022 Direct F1
transaction CMPI Common Stock Sale $811 -300 -0.01% $2.70 2,161,990 25 Feb 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Novo Holdings A/S is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.79 to $2.91. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price noted in this footnote.